[1]
A. Shiono, “A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: Insights from two institutions: Chemoradiotherapy in older patients with limited-disease small cell lung cancer”, Radiol Oncol, vol. 58, no. 3, pp. 432–443, Sep. 2024.